PUBLICATIONS
Virag, D., Homolak, J., Kodvanj, I., Babic Perhoc, A., Knezovic, A., Osmanovic Barilar, J., Salkovic-Petrisic, M. Preprint: Repurposing a digital kitchen scale for neuroscience research: a complete hardware and software cookbook for PASTA. 2020 bioRxiv doi: 10.1101/2020.04.10.035766
​
Homolak J. & Kodvanj I. Preprint: Widely Available Lysosome Targeting Agents Should Be Considered as a Potential Therapy for COVID-19. 2020 doi: 10.20944/preprints202003.0345.v2
​
​
Babic Perhoc A, Osmanovic Barilar J, Knezovic A, Farkas V, Bagaric R, Svarc A, Grünblatt E, Riederer P, Salkovic-Petrisic M. Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice.
Neuropharmacology. 2019 Apr;148:50-67. doi: 10.1016/j.neuropharm.2018.12.018.
Epub 2018 Dec 17. PubMed PMID: 30571958.
Knezovic A, Osmanovic Barilar J, Babic A, Bagaric R, Farkas V, Riederer P, Salkovic-Petrisic M. Glucagon-like peptide-1 mediates effects of oral galactose in streptozotocin-induced rat model of sporadic Alzheimer's disease.
Neuropharmacology. 2018 Jun;135:48-62. doi: 10.1016/j.neuropharm.2018.02.027.
Epub 2018 Feb 28. PubMed PMID: 29501615.
Riederer P, Korczyn AD, Ali SS, Bajenaru O, Choi MS, Chopp M, Dermanovic-Dobrota V, Grünblatt E, Jellinger KA, Kamal MA, Kamal W, Leszek J, Sheldrick-Michel TM, Mushtaq G, Meglic B, Natovich R, Pirtosek Z, Rakusa M, Salkovic-Petrisic M, Schmidt R, Schmitt A, Sridhar GR, Vécsei L, Wojszel ZB, Yaman H, Zhang ZG, Cukierman-Yaffe T. The diabetic brain and cognition.
J Neural Transm (Vienna). 2017 Nov;124(11):1431-1454. doi: 10.1007/s00702-017-1763-2.
Epub 2017 Aug 1. Review. PubMed PMID: 28766040.
Knezovic A, Loncar A, Homolak J, Smailovic U, Osmanovic Barilar J, Ganoci L, Bozina N, Riederer P, Salkovic-Petrisic M. Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?
J Neural Transm (Vienna). 2017 Jun;124(6):695-708. doi: 10.1007/s00702-017-1727-6.
Epub 2017 May 3. PubMed PMID: 28470423.
Hainsworth AH, Allan SM, Boltze J, Cunningham C, Farris C, Head E, Ihara M, Isaacs JD, Kalaria RN, Lesnik Oberstein SA, Moss MB, Nitzsche B, Rosenberg GA, Rutten JW, Salkovic-Petrisic M, Troen AM. Translational models for vascular cognitive impairment: a review including larger species.
BMC Med. 2017 Jan 25;15(1):16. doi: 10.1186/s12916-017-0793-9.
Review. PubMed PMID: 28118831; PubMed Central PMCID: PMC5264492.
Osmanovic-Barilar J, Salkovic-Petrisic M. Inconsistency in Preclinical and Clinical Trials Exploring The Role of Hormone Replacement Therapy in Alzheimer's Disease.
Clin Ther. 2016 Oct 6;38(10S):e4. doi: 10.1016/j.clinthera.2016.07.022.
PubMed PMID: 27673667.
Salkovic-Petrisic M, Knezovic A, Osmanovic-Barilar J, Smailovic U, Trkulja V, Riederer P, Amit T, Mandel S, Youdim MB. Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.
Life Sci. 2015 Sep1;136:108-19. doi: 10.1016/j.lfs.2015.06.026.
Epub 2015 Jul 6. PubMed PMID: 26159898.
Grünblatt E, Bartl J, Iuhos DI, Knezovic A, Trkulja V, Riederer P, Walitza S, Salkovic-Petrisic M. Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction.
J Mol Psychiatry. 2015 Jun 4;3(1):6. doi: 10.1186/s40303-015-0012-6.
eCollection 2015. PubMed PMID: 26110057; PubMed Central PMCID: PMC4479234.
Knezovic A, Osmanovic-Barilar J, Curlin M, Hof PR, Simic G, Riederer P, Salkovic-Petrisic M. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.
J Neural Transm (Vienna). 2015 Apr;122(4):577-92. doi: 10.1007/s00702-015-1394-4.
Epub 2015 Mar 26. PubMed PMID: 25808906.
Barilar JO, Knezovic A, Grünblatt E, Riederer P, Salkovic-Petrisic M. Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer's disease.
J Neural Transm (Vienna). 2015 Apr;122(4):565-76. doi: 10.1007/s00702-014-1323-y.
Epub 2014 Dec12. PubMed PMID: 25503661.
Sofic E, Salkovic-Petrisic M, Tahirovic I, Sapcanin A, Mandel S, Youdim M, Riederer P. Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30.
J Neural Transm (Vienna). 2015 Apr;122(4):559-64. doi:10.1007/s00702-014-1307-y.
Epub 2014 Sep 25. PubMed PMID: 25252744.
Sun P, Knezovic A, Parlak M, Cuber J, Karabeg MM, Deckert J, Riederer P, Hua Q, Salkovic-Petrisic M, Schmitt AG. Long-Term Effects of Intracerebroventricular Streptozotocin Treatment on Adult Neurogenesis in the Rat Hippocampus.
Curr Alzheimer Res. 2015;12(8):772-84. PubMed PMID: 26159196.
Salkovic-Petrisic M, Osmanovic-Barilar J, Knezovic A, Hoyer S, Mosetter K, Reutter W. Long-term oral galactose treatment prevents cognitive deficits in male Wistar rats treated intracerebroventricularly with streptozotocin.
Neuropharmacology. 2014 Feb;77:68-80. doi: 10.1016/j.neuropharm.2013.09.002.
Epub 2013 Sep 18. PubMed PMID: 24055495.
Salkovic-Petrisic M, Knezovic A, Hoyer S, Riederer P. What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research.
J Neural Transm (Vienna). 2013 Jan;120(1):233-52. doi: 10.1007/s00702-012-0877-9.
Epub 2012 Aug 12. Review. PubMed PMID: 22886150.
Salkovic-Petrisic M, Osmanovic-Barilar J, Brückner MK, Hoyer S, Arendt T, Riederer P. Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study.
J Neural Transm (Vienna). 2011 May;118(5):765-72. doi: 10.1007/s00702-011-0651-4.
Epub 2011 Apr 30. PubMed PMID: 21533606.
Kuljiš RO, Salković-Petrišić M. Dementia, diabetes, Alzheimer's disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics.
J Alzheimers Dis. 2011;25(1):29-41. doi: 10.3233/JAD-2011-101392.
Review. PubMed PMID: 21335659.
Bach-Rojecky L, Salković-Petrisić M, Lacković Z. Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection.
Eur J Pharmacol. 2010 May 10;633(1-3):10-4. doi: 10.1016/j.ejphar.2010.01.020.
Epub 2010 Feb 1. PubMed PMID: 20123097.
Vukelic D, Trkulja V, Salkovic-Petrisic M. Single oral dose of azithromycin versus 5 days of oral erythromycin or no antibiotic in treatment of campylobacter enterocolitis in children: a prospective randomized assessor-blind study.
J Pediatr Gastroenterol Nutr. 2010 Apr;50(4):404-10. doi: 10.1097/MPG.0b013e3181a87104.
PubMed PMID: 19881393.
Osmanovic J, Plaschke K, Salkovic-Petrisic M, Grünblatt E, Riederer P, Hoyer S. Chronic exogenous corticosterone administration generates an insulin-resistant brain state in rats.
Stress. 2010 Mar;13(2):123-31. doi: 10.3109/10253890903080379.
PubMed PMID: 19929311.
Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M, Riederer P, Hoyer S. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice. J Alzheimers Dis. 2010;19(2):691-704. doi: 10.3233/JAD-2010-1270.
PubMed PMID: 20110613.
Salkovic-Petrisic M, Osmanovic J, Grünblatt E, Riederer P, Hoyer S. Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta. J Alzheimers Dis. 2009;18(4):729-50. doi: 10.3233/JAD-2009-1184.
Review. PubMed PMID: 19661616.
Sapcanin A, Sofic E, Tahirovic I, Salkovic-Petrisic M, Hoyer S, Riederer P. Antioxidant capacity in rat brain after intracerebroventricular treatment with streptozotocin and alloxan--a preliminary study.
Neurotox Res. 2008 Apr;13(2):97-104.
PubMed PMID: 18515212.
Tahirovic I, Sofic E, Sapcanin A, Gavrankapetanovic I, Bach-Rojecky L, Salkovic-Petrisic M, Lackovic Z, Hoyer S, Riederer P. Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.
Neurochem Res. 2007 Oct;32(10):1709-17.
Epub 2007 Jun 29. PubMed PMID: 17605105.
Grünblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S. Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein.
J Neurochem. 2007 May;101(3):757-70.
PubMed PMID: 17448147.
Tahirovic I, Sofic E, Sapcanin A, Gavrankapetanovic I, Bach-Rojecky L, Salkovic-Petrisic M, Lackovic Z, Hoyer S, Riederer P. Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.
J Neural Transm Suppl. 2007;(72):235-40.
PubMed PMID: 17982899.
Salkovic-Petrisic M, Hoyer S. Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach.
J Neural Transm Suppl. 2007;(72):217-33.
Review. PubMed PMID: 17982898.
Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P. Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway.
J Neurochem. 2006 Feb;96(4):1005-15.
Epub 2006 Jan 12. PubMed PMID: 16412093.
Salkovic-Petrisic M, Lackovic Z, Hoyer S, Riederer P. Central administration of alloxan impairs glucose tolerance in rats.
J Neural Transm (Vienna). 2005 Oct;112(10):1391-5.
PubMed PMID: 16184320.
Salković-Petrisić M, Lacković Z. Intracerebroventricular administration of betacytotoxics alters expression of brain monoamine transporter genes. J Neural Transm (Vienna). 2003 Jan;110(1):15-29.
PubMed PMID: 12541010.
Salković-Petrisić M, Mrzljak A, Lacković Z. Usage of the Internet pharmacology resources among European pharmacologists: a preliminary investigation.
Fundam Clin Pharmacol. 2001 Feb;15(1):55-60.
PubMed PMID: 11468014.
Petrisić MS, Augood SJ, Bicknell RJ. Monoamine transporter gene expression in the central nervous system in diabetes mellitus.
J Neurochem. 1997 Jun;68(6):2435-41.
PubMed PMID: 9166737.
Salković M, Sabolić I, Lacković Z. Striatal dopaminergic D1 and D2 receptors after intracerebroventricular application of alloxan and streptozocin in rat.
J Neural Transm Gen Sect. 1995;100(2):137-45.
PubMed PMID: 8962683.
Salković M, Lacković Z. Brain D1 dopamine receptor in alloxan-induced diabetes.
Diabetes. 1992 Sep;41(9):1119-21.
PubMed PMID: 1386820.
Lacković Z, Salković-Petrisić M, Mitrović N, Horvat A. [Chemical warfare agents].
Lijec Vjesn. 1991 Jul-Aug;113(7-8):247-57.
Review. Croatian. PubMed PMID: 1762492.
Lacković Z, Salković M, Kuci Z, Relja M. Effect of long-lasting diabetes mellitus on rat and human brain monoamines.
J Neurochem. 1990 Jan;54(1):143-7.
PubMed PMID: 2293606.
Lacković Z, Salković M. Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction.
Life Sci. 1990;46(1):49-54. PubMed PMID: 1688991.